[
  {
    "ts": null,
    "headline": "Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge?",
    "summary": "LH stock surges 25.6% this year, powered by specialty testing expansion, key acquisitions and solid financials.",
    "url": "https://finnhub.io/api/news?id=fabebd208e29ea64d029e12132f159254ba9b1e94ecd45b2f092e0162011cf53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750249680,
      "headline": "Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge?",
      "id": 135371187,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "LH stock surges 25.6% this year, powered by specialty testing expansion, key acquisitions and solid financials.",
      "url": "https://finnhub.io/api/news?id=fabebd208e29ea64d029e12132f159254ba9b1e94ecd45b2f092e0162011cf53"
    }
  },
  {
    "ts": null,
    "headline": "GeneCentric Announces Series C Financing to Advance Novel Liquid Biopsy Platform for Precision Oncology",
    "summary": "DURHAM, N.C., June 18, 2025--GeneCentric Announces $8 Million Series C Financing to Advance Novel GenomicsNext Liquid Biopsy Platform for Precision Oncology",
    "url": "https://finnhub.io/api/news?id=19dbbd33e07ed541087e03fdd3786f868ca22ad3e60134c27a2886d581feda97",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750248000,
      "headline": "GeneCentric Announces Series C Financing to Advance Novel Liquid Biopsy Platform for Precision Oncology",
      "id": 135371343,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "DURHAM, N.C., June 18, 2025--GeneCentric Announces $8 Million Series C Financing to Advance Novel GenomicsNext Liquid Biopsy Platform for Precision Oncology",
      "url": "https://finnhub.io/api/news?id=19dbbd33e07ed541087e03fdd3786f868ca22ad3e60134c27a2886d581feda97"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care",
    "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp Whole Health Solutions to support the growing needs of functional medicine, integrative medicine and primary care providers in delivering holistic care. The solution launches specialized test panels and a tailored test menu of more than 1,000 scientifically backed biomarkers for cardiometabolic health, hormones, micronutrients, longevity and whole body wellness.",
    "url": "https://finnhub.io/api/news?id=c7efc4b80c10864e5872ca70fbb5acee367808aadadda22ad99ac38382f89637",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750244400,
      "headline": "Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care",
      "id": 135371344,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp Whole Health Solutions to support the growing needs of functional medicine, integrative medicine and primary care providers in delivering holistic care. The solution launches specialized test panels and a tailored test menu of more than 1,000 scientifically backed biomarkers for cardiometabolic health, hormones, micronutrients, longevity and whole body wellness.",
      "url": "https://finnhub.io/api/news?id=c7efc4b80c10864e5872ca70fbb5acee367808aadadda22ad99ac38382f89637"
    }
  },
  {
    "ts": null,
    "headline": "PreciseDx Continues Path to Commercial Launch: Secures Additional Funding and Announces New Leadership",
    "summary": "PreciseDx, the leading innovator behind PreciseBreast, a novel breast cancer diagnostic that is powered by OncoIntelligence, their proprietary AI-platform, today announced the successful closing of $11 million in funding and two key leadership hires. This latest round of funding was led by Eventide Asset Management (\"Eventide\"), Merck Global Health Innovation Fund and Philips Ventures and included Labcorp, Quest Diagnostics, GenHenn Capital Venture, along with other existing investors. This fund",
    "url": "https://finnhub.io/api/news?id=2b5fe3652c0b6a9313ce88f23338a98d74377a6966c66871ea99e755f787c3d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750244220,
      "headline": "PreciseDx Continues Path to Commercial Launch: Secures Additional Funding and Announces New Leadership",
      "id": 135353195,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "PreciseDx, the leading innovator behind PreciseBreast, a novel breast cancer diagnostic that is powered by OncoIntelligence, their proprietary AI-platform, today announced the successful closing of $11 million in funding and two key leadership hires. This latest round of funding was led by Eventide Asset Management (\"Eventide\"), Merck Global Health Innovation Fund and Philips Ventures and included Labcorp, Quest Diagnostics, GenHenn Capital Venture, along with other existing investors. This fund",
      "url": "https://finnhub.io/api/news?id=2b5fe3652c0b6a9313ce88f23338a98d74377a6966c66871ea99e755f787c3d2"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons to Avoid LH and 1 Stock to Buy Instead",
    "summary": "Labcorp’s 14.6% return over the past six months has outpaced the S&P 500 by 13%, and its stock price has climbed to $259.45 per share. This run-up might have investors contemplating their next move.",
    "url": "https://finnhub.io/api/news?id=8e84b76969dfed08806771fc84660010d40db4fd10daac573f0563e3cb2d960f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750219272,
      "headline": "3 Reasons to Avoid LH and 1 Stock to Buy Instead",
      "id": 135371346,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp’s 14.6% return over the past six months has outpaced the S&P 500 by 13%, and its stock price has climbed to $259.45 per share. This run-up might have investors contemplating their next move.",
      "url": "https://finnhub.io/api/news?id=8e84b76969dfed08806771fc84660010d40db4fd10daac573f0563e3cb2d960f"
    }
  }
]